Description
The test evaluates the speed of metabolization of caffeine. The genetic analysis involves the interrogation of the CYP1A gene which encodes the cytochrome P450 protein, which at the liver level is the primary enzyme involved in the metabolism of caffeine. The unfavourable variant of the gene leads to a greater risk of side effects such as nausea, tachycardia, insomnia and hypertension.





